Clinical Trial Compliance
The rights and safety of research participants are prioritized throughout your study
Your clinical trial is less likely to suffer from downtime due to inspections by regulators
Your clinical study data is accurate and trustworthy
Do you want to learn more about how to navigate the various regulatory requirements for your research program?
Our Human Research Protection Program
ethica CRO’s HRPP oversees all our research activities to ensure that our research programs constantly conform to all applicable laws and regulations. These duties include—and are not limited to—internal monitoring of research activities, vendor selection processes, and the implementation of a comprehensive unanticipated problem reporting and management system.
To learn more about our HRPP, please visit our Human Research Protection Program page.
Our Approach to Regulatory Compliance for Clinical Research
At ethica CRO, compliance is an integral component of our participant-centric approach to clinical research. Above all, we are committed to protecting the rights and welfare of all research participants in all of our research activities.
Our Compliance with Regional, National, and International Guidelines
At ethica CRO, we are proud to be the first accredited CRO in the world. Thanks to our robust SOPs and comprehensive HRPP, we have successfully maintained our accreditation for nearly fifteen years.
ethica CRO’s clinical research activities and HRPP adhere to all applicable international, American and Canadian principles, laws, and regulations, including:
- UNESCO Universal Declaration on Bioethics and Human Rights
- World Medical Association (WMA), Ethical Principles for Medical Research Involving Human Subjects (Declaration of Helsinki)
- International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), Good Clinical Practice: Consolidated Guideline (GCP)
- Council for International Organizations of Medical Sciences (CIOMS), International Ethical Guidelines for Health-Related Research Involving Human Subjects
Canadian Acts, Regulations and Guidelines
- Personal Information Protection and Electronic Documents Act (PIPEDA)
- Food and Drug Regulations of Health Canada – Part C
- Division 2 – GMP Guidelines
- Division 5 – Drug for Clinical Trials Involving Human Subjects
- Natural Health Products Regulations of Health Canada – Part 4 – Clinical Trials Involving Human Subjects
- Medical Device Regulations from Government of Canada Medical – Part 3 – “Medical Devices for Investigational Testing Involving Human Subjects”
- Cannabis Act and Regulations
- Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada, Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS)
US Acts, Regulations and Guidelines
- Health Insurance Portability and Accountability Act (HIPAA) and Regulations
- 21 CRF Part 11 – Electronic Records; Electronic Signatures
- 21 CRF Part 50 – Protection of Human Subjects
- 21 CRF Part 54 – Financial Disclosure by Clinical Investigators
- 21 CRF Part 56 – Institutional Review Boards
- 21 CRF Part 210 – cGMP in Manufacturing, Processing, Packing, or Holding of Drugs
- 21 CRF Part 211 – cGMP for Finished Pharmaceuticals
- 21 CRF Part 312 – Investigational New Drug application
- 21 CRF Part 812 – Investigational Device Exemptions
- 45 CRF Part 46 – Protection of Human Subjects
- Section 801 – Food and Drug Administration Amendments Act (FDAAA 801)
- National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, Ethical Principles and Guidelines for the Protection of Human Subjects of Research (Belmont Report)